References
- Emren W., O'Neill L. Clinical significance of antinuclear antibodies. Arthritis Rheum 1997; 40: 1612–18
- Slater C. A., Davis R. B., Shmerling R. H. Antinuclear antibody testing. A study of clinical utility. Arch Int Med 1996; 156: 1421–5
- Wiik A. S. Anti‐nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005; 34: 122–4
- Arbuckle M. R., McClain M. T., Rubertone M. V., Scofield R. H., Dennis G. J., James J. A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–33
- Myckatyn S. O., Russell A. S. Outcome of positive antinuclear antibodies in individuals without connective tissue disease. J Rheumatol 2003; 30: 736–9
- Collard R. C., Koehler R. P., Mattson D. H. Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology 1997; 49: 857–61
- Macgeorge J., Frazer I. H., Cunninham A. Autoantibodies, sheep cell agglutinins and anti‐albumin antibodies in alcoholic liver disease. J Clin Lab Immunol 1984; 13: 21–4
- Blaes F., Klotz M., Huwer H., Straub U., Kalweit G., Schimrigk K., et al. Antineural and antinuclear autoantibodies are of prognostic relevance in non‐small cell lung cancer. Ann Thorac Surg 2000; 69: 254–8
- Guyomard S., Salles G., Coudurier M., Rousset H., Coiffier B., Bienvenu J., et al. Prevalence and pattern of antinuclear autoantibodies in 347 patients with non‐Hodgkin's lymphoma. Br J Haematol 2003; 123: 90–9
- Pinsky M. R. Dysregulation of the immune response in severe sepsis. Am J Med Sci 2004; 328: 220–9
- Tektonidou M. G., Anapliotou M., Vlachoyiannopoulos P., Moutsopoulos H. M. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 2004; 63: 1159–61
- Vaile J. H., Dyke L., Kherani R., Johnston C., Higgins T., Russell A. S. Is high titre ANA specific for connective tissue disease?. Clin Exp Rheumatol 2000; 18: 433–8
- Suarez‐Almazor M. E., Gonzalez‐Lopez L., Gamez‐Nava J. I., Belseck E., Kendall C. J., Davis P. Utilisation and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol 1998; 25: 1980–5
- Maddison P. J., Stephens C., Briggs D., Welsh K. I., Harvey G., Whyte J., et al. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. Medicine 1993; 72: 103–12
- Tan E. M., Feltkamp T. E., Smolen J. S., Butcher B., Dawkins R., Fritzler M. J., et al. Range of antinuclear antibodies in ‘healthy’ individuals. Arthritis Rheum 1997; 40: 1601–11